Subscribe


PD breaking news – EBOS acquires ZEST healthcare communications business

Deal part of EBOS’ expanding presence in the delivery and administration of specialty pharmacy products. 

Symbion parent company EBOS has just announced the acquisition of Sydney-based ZEST Healthcare Communications, with EBOS ceo Patrick Davies saying the deal would “add valuable new specialised healthcare resources to complement the range of existing distribution and market access services in the Group”.

He said pharmaceutical companies are increasingly seeking partners with deep local sector knowledge and the skills required to create customised solutions for the delivery and administration of specialty products.

“ZEST has been a pioneer and leader in providing a range of specialised services to pharmaceutical companies for ten years now…the combined strength of EBOS and ZEST will enable full end-to-end service provision for selected products,” Davies said.

This would include everything from storage and distribution, to program creation and management, as well as community-based access and administration, he added.

Davies said there are many new products that require innovative delivery models, and EBOS is adapting its business to participate in these emerging opportunities.

More details in Monday’s issue of Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 30 Oct 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

21 Sep

Travel Specials 21 Sep 17 - WELCOME to Pharmacy Daily's travel feature. Each ...


21 Sep

Dispensary Corner 21 Sep 17 - AN INDIANA food processing plant accidently turned ...


21 Sep

Pfizer sues J&J - ON WEDNESDAY, Pfizer filed a complaint in ...


21 Sep

Singulair queried - MERCK Sharp & Dohme's asthma medication Singulair ...


21 Sep

AIHW recruiting - THE Australian Institute of Health and Welfare ...


21 Sep

Dementia publication fires up neurons - UNIVERSITY of Queensland experts are keeping people ...


21 Sep

Online medicine risks - THE Royal Australian College of General Practitioners ...


21 Sep

Antibiotic paucity - THE World Health Organization has reiterated its ...


21 Sep

Pharmacist-led digital care outcomes - PHARMACIST-LED digital healthcare can improve anti-hypertensive medication ...


21 Sep

Indication extensions - THE Therapeutic Goods Administration has posted broadened ...


21 Sep

Lax-Sachets recall - AFT Pharmaceuticals, in consultation with the TGA, ...


21 Sep

S4 to S3 switch plans - WHILE it is understood that the individual ...


21 Sep

APC Council ‘renewal’ - THE president of the Australian Pharmacy Council ...


21 Sep

TGA labeling rules update - TO REDUCE medication errors, medicine labels need ...


20 Sep

Dermal Therapy Very Dry Skin Lotion - DERMAL Therapy Very Dry Skin Lotion is ...


20 Sep

Sensitive SPF 50+ Sunscreen - TO cater for those with sensitive skin, ...


20 Sep

Clinical Protection Anti-Perspirant Deodorant by Dove - DOVE Clinical Protection Anti-Perspirant Deodorant combines clinical ...


20 Sep

Hello Brows 2-in-1 Stylus by Ulta3 - ULTA3 Hello Brows 2-in-1 Stylus is a ...


20 Sep

Dispensary Corner 20 Sep 17 - TALK about flush with cash - Geneva ...


20 Sep

Medlab 20 year patent - AUSTRALIAN-LISTED medical life science company Medlab Clinical ...



Show Pharmacy Daily items by month: